MARATTO

article · Benha Journal of Applied Sciences

Injection of Polidocanol and mixed Digoxin and Furosemide in Treatment of Warts

2024Open accessBenha University

Abstract

Background: Many different therapies are available for patients with numerous warts. The majority of these treatments target the diseased tissue directly, but sometimes the amount of cellular damage is insufficient to release the cytokines that kill the latent virus. In such cases, patients seek for other treatments. In this article, we will have a look at the results of treating cutaneous warts with intralesional polidocanol and intralesional combination furosemide and digoxin. Final thoughts: Treatment of cutaneous warts with injections of Polidocanol and a combination of intralesional furosemide and digoxin seems to be a safe, highly successful, and adverse effect-minimizing option. Many different therapies are available for patients with numerous warts. The majority of these treatments target the diseased tissue directly, but sometimes the amount of cellular damage is insufficient to release the cytokines that kill the latent virus. In such cases, patients seek for other treatments. In this article, we will have a look at the results of treating cutaneous warts with intralesional polidocanol and intralesional combination furosemide and digoxin. Final thoughts: Treatment of cutaneous warts with injections of Polidocanol and a combination of intralesional furosemide and digoxin seems to be a safe, highly successful, and adverse effect-minimizing option.

Research topics

  • Polysaccharides and Plant Cell Walls
  • Plant Surface Properties and Treatments

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/bjas.2024.332505.1530

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.